These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37586167)

  • 1. An integration-free iPSC line ZZUNEUi029-A derived from peripheral blood mononuclear cells of a patient with familial hypercholesterolemia carrying a mutation in LDLR gene.
    Zhu K; Zhao J; Qin F; Chen X; Xu H; Li X; Tao H
    Stem Cell Res; 2023 Sep; 71():103182. PubMed ID: 37586167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cell line ICGi037-A, obtained by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia due to heterozygous p.Trp443Arg mutations in LDLR.
    Zakharova IS; Shevchenko AI; Tmoyan NA; Elisaphenko EA; Kalinin AP; Sleptcov AA; Nazarenko MS; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
    Stem Cell Res; 2022 Apr; 60():102703. PubMed ID: 35152179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cell line ICGi038-A, obtained by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia due to compound heterozygous c.1246C > T/c.940 + 3_940 + 6del mutations in LDLR.
    Zakharova IS; Shevchenko AI; Tmoyan NA; Elisaphenko EA; Zubkova ES; Sleptcov AA; Nazarenko MS; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
    Stem Cell Res; 2022 Apr; 60():102702. PubMed ID: 35152178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two familial hypercholesterolemia patient-specific induced pluripotent stem cell lines harboring heterozygous mutations in the LDLR gene.
    Gao J; Li J; Xu L; Yan CD; Knowles JW; Wu JC
    Stem Cell Res; 2024 Aug; 78():103463. PubMed ID: 38852422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort Generation and Characterization of Patient-Specific Familial Hypercholesterolemia Induced Pluripotent Stem Cells.
    Omer L; Hudson EA; Hudgins LC; Boyd NL
    Stem Cells Dev; 2021 Jun; 30(12):632-640. PubMed ID: 34029164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human induced pluripotent stem cells line (PNUSCRi004-A) from a Parkinson's disease patient carrying L483P, A495P and V499V mutations.
    Moon HJ; Lee N; Moon JY; Lee JH; Kim JH
    Stem Cell Res; 2023 Apr; 68():103051. PubMed ID: 36805467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cell line, NIMHi009-A, from PBMCs of an adult healthy male.
    Arunachal G; Milind Nimonkar M; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
    Stem Cell Res; 2024 Apr; 76():103349. PubMed ID: 38368738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
    Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
    Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a healthy heavy smoker patient-derived induced pluripotent stem cell line UHOMi007-A from peripheral blood mononuclear cells.
    Ahmed E; Fieldès M; Bourguignon C; Mianné J; Petit A; Amel N; Foisset F; Bourdais C; Vachier I; Assou S; De Vos J; Bourdin A
    Stem Cell Res; 2024 Jun; 77():103437. PubMed ID: 38723411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a human induced pluripotent stem cell line PUMCHi019-A from a dominant optic atrophy patient with an OPA1 mutation.
    Sun Z; Wu S; Zhu T; Wei X; Han X; Zou X; Sui R
    Stem Cell Res; 2022 Apr; 60():102705. PubMed ID: 35152176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
    Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
    Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integration-free iPSC line (SDQLCHi013-A) derived from a patient with maple syrup urine disease carrying compound heterozygote mutations in BCKDHA gene.
    Zhang H; Ma Y; Li X; Yang X; Li Y; Guan J; Dong R; Gai Z; Liu Y
    Stem Cell Res; 2019 Dec; 41():101585. PubMed ID: 31775088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of a human induced pluripotent stem cell line (XWHNi001-A) derived from an Alzheimer's disease patient with mutation in the APP gene.
    Wei C; Lu X; Zou Q; Gong S; Chen Y; Lyu J; Jia J
    Stem Cell Res; 2022 Apr; 60():102690. PubMed ID: 35149456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an induced pluripotent stem cell line (KNIHi001-A) by reprogramming peripheral blood mononuclear cells isolated from a patient with Parkinson's disease.
    Baek D; Lee KG; Sohn HY; Park JH; Lee HK; Bayarsaikhan G; Yoo SW; Lee B; Kim JS; Koh YH; Kwon M
    Stem Cell Res; 2024 Apr; 76():103358. PubMed ID: 38447455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell line (ZZUi034-A) from a 65 year old Chinese female donor with sendai virus reprogramming protocol.
    Zhang Y; Zhu J; Dai Y; Wang L; Liu R; Guo X
    Stem Cell Res; 2022 Jul; 62():102788. PubMed ID: 35462158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
    Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
    Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of iPSC line (FMCPGHi003-A) from human PBMCs of a patient with Familial hemiplegic migraine type 3.
    Wang T; Li Y; Yang C; Yuan H; Na W; Yu S
    Stem Cell Res; 2024 Sep; 79():103465. PubMed ID: 38880015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors.
    Vlahos K; Sourris K; Yi Kuah J; Graham A; Suter A; Howden SE; Stanley EG; Elefanty AG
    Stem Cell Res; 2023 Jun; 69():103109. PubMed ID: 37150143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
    Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
    Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female.
    Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS
    Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.